Global Clinical Nutrition Market Insights: Aging Populations and Chronic Diseases Fueling Industry Expansion

 [Hyderabad, April 30th, 2025] The global clinical nutrition market is experiencing a significant surge, projected to grow from USD 52.4 billion in 2023 to USD 89.7 billion by 2031, expanding at a CAGR of 6.9% ClearView Market Insights, 2024. This expansion is driven by increasing demand across three key sectors:

Request Sample @ https://clearviewmarketinsights.com/report-details/global-clinical-nutrition-market/

Aging Population and Chronic Diseases:

·       Cancer Care: Specialized enteral nutrition products improve treatment tolerance, reducing hospital stays by up to 20%.

·       Diabetes Management: Tailored formulas help regulate glycemic response, reducing HbA1c levels by an average of 1.2%.

·       Geriatric Nutrition: Multinutrient supplements with muscle-preserving proteins slow sarcopenia progression by 30%.

Pediatric and Neonatal Nutrition:

·       Preterm Infant Care: Human milk fortifiers enriched with DHA and ARA increase survival rates by 12%.

·       Food Allergy Solutions: Hypoallergenic infant formulas are projected to see a 9.5% CAGR through 2030, driven by rising food sensitivity cases.

·       Malnutrition Eradication: UNICEF-supported programs integrating ready-to-use therapeutic foods (RUTFs) aim to cut global child wasting rates by 25% by 2027.

Personalized and Precision Nutrition:

·       Genetic Nutrition Profiling: Companies like Nutrigenomix offer DNA-based dietary recommendations improving treatment adherence by 40%.

·       Microbiome-Targeted Formulas: Synbiotic supplements enhance gut health, with clinical trials showing 20% faster recovery post-antibiotic use.

·       AI-Powered Meal Planning: Digital platforms design real-time diet adjustments based on continuous glucose monitoring (CGM) data.

2024 Breakthroughs

Commercialisation Milestones

Innovation Company Impact:

·       Plant-Based Clinical Nutrition Nestlé Health Science 15% growth in dairy-free medical nutrition demand

·       Microbiome Therapeutics Viome Launch of gut-targeted personalized supplements for cancer recovery

·       3D-Printed Nutritional Solutions Fit3D Customizable supplements for ICU patients, improving nutrient absorption rates by 25%

Investment & R&D Trends:

·       Startup Funding: USD 2.8 billion raised in 2023, led by personalized nutrition and gut health startups.

Corporate R&D:

·       Nestlé Health Science: USD 600M investment in microbiome therapies

·       Abbott Laboratories: Expansion of precision nutrition portfolio with AI-integrated platforms

Executive Insights:

·       "Precision nutrition will revolutionize patient care, allowing interventions that are truly individualized at the genetic and microbiome level."
— Dr. Sophia Martinez, Chief Medical Officer, Abbott Nutrition

·       "Clinical nutrition is no longer about just feeding patients—it's a front-line therapy against disease progression and hospital readmissions."
— Prof. David Liu, Harvard Medical School, Department of Nutrition

Regional Analysis

·       North America (XX% Market Share)

·       Medicaid and Medicare reforms expanding nutrition coverage in oncology and chronic care management.

·       Major hospital chains integrating personalized nutrition protocols to reduce readmissions.

·       Europe (30% Share)

·       EU Medical Device Regulation (MDR) expands definition of clinical nutrition products, enhancing regulatory oversight.

·       Rising elderly population drives demand for enteral feeding solutions, especially in Germany, France, and Italy.

·       Asia-Pacific (22% Share)

·       China’s Healthy China 2030 Initiative promoting hospital nutrition programs.

·       India’s government mandates nutrition support as part of public health insurance schemes.

Future Roadmap:

·       2025: Mainstream adoption of microbiome-based clinical nutrition in oncology treatment pathways.

·       2027: AI-driven predictive models for hospital malnutrition risk launched across top U.S. and EU hospitals.

·       2030: Full integration of personalized nutrition into electronic health records (EHRs) enabling real-time therapeutic adjustments.

Company Spotlight

·       Nestlé Health Science:

·       Market Position: 19% share in global clinical nutrition market.

·       2024 Innovation: Launch of plant-based enteral feeding solutions for chronic care settings.

·       Growth Strategy: Strategic acquisitions of microbiome and personalized nutrition startups.

Abbott Laboratories

·       Breakthrough: CGM-integrated nutrition planning for diabetes management.

·       Partnerships: Collaboration with Dexcom and Medtronic for AI-based dietary management tools.

 

For more insights, visit https://clearviewmarketinsights.com/report-store

 

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

 

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-736

Comments

Popular posts from this blog

Asia-Pacific Veterinary Equipment and Disposables Market to Surpass USD 1.85 Billion by 2032, Driven by Rising Pet Adoption and Veterinary Infrastructure Development

Middle East and Africa Pig Launchers and Receivers Market to Reach USD 141.3 Million by 2030 Amid Expanding Pipeline Networks and Maintenance Priorities

Europe Veterinary Equipment and Disposables Market to Reach USD 1.47 Billion by 2032, Fueled by Rising Pet Healthcare Demand and Technological Advancements